Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice

Ken Arimura1, Kazutetsu Aoshiba, Takao Tsuji

  • 1Pulmonary Division, Graduate School of Medical Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

Lung
|September 12, 2012
PubMed
Abstract

Insights

Chronic systemic inflammation causes DNA damage in lung cells before visible changes occur. This study reveals persistent DNA double-strand breaks in alveolar cells due to low-grade inflammation.

Area of Science:

  • Pulmonary medicine
  • Inflammation research
  • Genotoxicology

Background:

  • The impact of systemic inflammation on lung health is not well understood.
  • This study investigates if chronic low-grade systemic inflammation damages alveolar wall cells.

Purpose of the Study:

  • To determine if chronic low-grade systemic inflammation induces DNA damage in pulmonary alveolar cells.
  • To assess the effects of both chronic and acute systemic inflammation on lung tissue.

Main Methods:

  • Induced chronic low-grade systemic inflammation in mice using lipopolysaccharide (LPS) via sustained-release pellets for 90 days.
  • Induced acute systemic inflammation with a single LPS injection.
  • Examined lung histology and genetic damage (DNA double-strand breaks) in alveolar epithelial and endothelial cells.

Main Results:

  • Chronic LPS exposure (30-90 days) did not cause significant lung architectural changes but doubled DNA double-strand breaks (DSBs) in alveolar epithelial and endothelial cells.
  • Acute LPS exposure also doubled DSBs in these cells within 24 hours, with levels returning to baseline by 48 hours.
  • Markers of DNA damage included γH2AX and phosphorylated 53BP1.

Conclusions:

  • Chronic systemic inflammation leads to persistent DNA damage in alveolar epithelial and endothelial cells.
  • This damage occurs prior to observable architectural alterations in the lung tissue.
  • Suggests a potential mechanism for lung compromise under sustained inflammatory conditions.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...